Market Insights Health Medical Technology Medical Devices

Ophthalmic Devices - Netherlands

Netherlands

The projected revenue in the Ophthalmic Devices market market in the Netherlands is expected to reach €0.54bn by 2024.
It is anticipated that there will be an annual growth rate (CAGR 2024-2029) of 4.10%, leading to a market volume of €0.66bn by 2029.
In comparison to other countries worldwide, the United States is projected to generate the highest revenue in this market, with €12,980.00m expected in 2024.
The Netherlands is experiencing a surge in demand for innovative ophthalmic devices, driven by its robust healthcare infrastructure and high prevalence of age-related eye diseases.

Key regions: Germany, Italy, France, Japan, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Ophthalmic Devices market in Netherlands has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to the development of the market in the country. Customer preferences in the Netherlands have played a significant role in the growth of the Ophthalmic Devices market. Dutch consumers have shown a strong preference for high-quality and technologically advanced products. They value products that offer convenience, durability, and ease of use. As a result, manufacturers have focused on developing innovative ophthalmic devices that meet these preferences. This has led to an increase in the availability and adoption of advanced ophthalmic devices in the market. Trends in the market have also contributed to the growth of the Ophthalmic Devices market in the Netherlands. One notable trend is the increasing demand for refractive surgery procedures, such as LASIK and PRK. This trend can be attributed to the growing awareness and acceptance of these procedures among the Dutch population. As a result, there has been a higher demand for ophthalmic devices used in refractive surgery, such as excimer lasers and femtosecond lasers. Another trend in the market is the rising prevalence of age-related eye diseases, such as cataracts and age-related macular degeneration (AMD). The aging population in the Netherlands has led to a higher incidence of these diseases, driving the demand for ophthalmic devices used in their diagnosis and treatment. This includes devices such as intraocular lenses and retinal imaging systems. Local special circumstances have also influenced the development of the Ophthalmic Devices market in the Netherlands. The country has a well-developed healthcare system with a high level of healthcare expenditure. This has facilitated the accessibility and affordability of ophthalmic devices for both healthcare providers and patients. Additionally, the presence of renowned ophthalmic research institutes and medical centers in the country has fostered innovation and collaboration in the field of ophthalmology. Underlying macroeconomic factors have also played a role in the growth of the Ophthalmic Devices market in the Netherlands. The country has a stable economy with a high per capita income, which has allowed consumers to afford and invest in ophthalmic devices. Furthermore, the government's focus on healthcare and the provision of universal healthcare coverage has contributed to the demand for ophthalmic devices in the country. In conclusion, the Ophthalmic Devices market in the Netherlands has experienced steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The Dutch population's preference for high-quality and technologically advanced products, along with the increasing demand for refractive surgery procedures and the rising prevalence of age-related eye diseases, has driven the growth of the market. The country's well-developed healthcare system, presence of renowned research institutes, and stable economy have also contributed to the development of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.